Antimony chelates for targeted auger therapy and imaging diagnostics
OwnerJonathan W. Engle, Aeli Olson +3inventors
InventorsJonathan W. Engle, Aeli Olson, Nikki Thiele, Briana R. Schrage, Md Faizul Islam
Life of this patent
Estimating the term…
Abstract
Antimony (Sb) chelates for use in targeted auger therapy and imaging diagnostics are provided. Also provided are methods of treating a subject in need of treatment using the antimony chelates. The chelates comprise a chelating ligand that binds an Sb radionuclide in a +5-oxidation state, such as 119Sb and 117Sb. The chelating ligand renders the Sb radionuclide stable and inert in vivo and enables the conjugation of the chelate to a biological targeting vector.
Claims20
An antimony chelate comprising an antimony (Sb(V)) radionuclide bound to a chelating ligand having the chemical structure:
- or a pharmaceutically acceptable salt thereof, where Ar1, Ar2, and Ar3 are independently selected from substituted or unsubstituted catechol groups and substituted or unsubstituted hydroxypyridinone (HOPO) groups.
A method of treating a subject in need of treatment, the method comprising administering a therapeutically effective amount of the antimony chelate comprising an antimony (Sb(V)) radionuclide bound to a chelating ligand having the chemical structure:
- or a pharmaceutically acceptable salt thereof, where Ar1, Ar2, and Ar3 are independently selected from substituted or unsubstituted catechol groups and substituted or unsubstituted hydroxypyridinone (HOPO) groups.
Dependencies are inferred from the claim text.